{
  "fullName": "Gregg C. Fonarow",
  "slug": "gregg-c-fonarow",
  "title": "MD",
  "specialty": "Cardiology Outcomes",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 199,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "The obesity paradox is the finding in some studies of a lower mortality rate for overweight or obese people within certain subpopulations. The paradox has been observed in people with cardiovascular disease and cancer. Explanations for the paradox range from excess weight being protective to the statistical association being caused by methodological flaws such as confounding, detection bias, reverse causality, or selection bias.",
  "aiSummary": "Gregg C. Fonarow is a cardiology outcomes specialist with an H-index of 199 at UCLA (Faculty). Has been published in Nature Reviews Cardiology, JAMA, New England Journal of Medicine. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "UCLA",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Cardiology Outcomes"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.",
      "journal": "Circulation",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1161/CIR.0000000000001063",
      "pubmedId": "35363499",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35363499/"
    },
    {
      "title": "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.",
      "journal": "J Am Coll Cardiol",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1016/j.jacc.2021.12.012",
      "pubmedId": "35379503",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35379503/"
    },
    {
      "title": "Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction.",
      "journal": "Drugs",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1007/s40265-023-01887-4",
      "pubmedId": "37254024",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37254024/"
    },
    {
      "title": "Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.",
      "journal": "J Am Coll Cardiol",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1016/j.jacc.2021.01.030",
      "pubmedId": "33736829",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33736829/"
    },
    {
      "title": "Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.",
      "journal": "Eur J Heart Fail",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1002/ejhf.2115",
      "pubmedId": "33605000",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33605000/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:14.000Z",
  "openalexId": "https://openalex.org/A5070928171",
  "bio": "## Dr. Gregg C. Fonarow: A Biography\n\nDr. Gregg C. Fonarow stands as a notable figure in contemporary cardiology, recognized particularly for his contributions to improving outcomes in heart failure, acute myocardial infarction, and related cardiovascular conditions. While specific details of his private practice and its location remain undisclosed, his widespread influence stems from his academic contributions, research endeavors, and commitment to advancing the field of cardiology outcomes. This biography seeks to illuminate the trajectory of Dr. Fonarow's career, highlighting his medical philosophy, clinical expertise, research impact, and lasting legacy.\n\n### 1. Early Life and Education\n\nInformation regarding Dr. Fonarow's early life and formative influences is limited. However, it is evident from his career trajectory that he possessed a strong academic foundation and a deep commitment to scientific inquiry. He pursued his medical education at a leading institution, likely engaging in rigorous coursework and clinical rotations that ignited his passion for cardiology.\n\nHis medical training would have encompassed a comprehensive understanding of human physiology, pathophysiology, and pharmacology, with a specific emphasis on the cardiovascular system. He would have mastered the principles of internal medicine, serving as the bedrock for his future specialization. During his residency, he likely rotated through various cardiology subspecialties, including interventional cardiology, electrophysiology, and heart failure, ultimately gravitating towards the study and improvement of cardiology outcomes.\n\nA significant portion of his training would have involved direct patient care, allowing him to develop critical diagnostic and therapeutic skills under the guidance of experienced cardiologists. He would have encountered a diverse range of cardiovascular conditions, including coronary artery disease, valvular heart disease, arrhythmias, and heart failure, providing invaluable practical experience that shaped his clinical acumen.\n\nFurthermore, Dr. Fonarow likely engaged in research activities during his training, contributing to ongoing studies and presenting his findings at scientific conferences. This early exposure to research would have fostered his interest in clinical investigation and laid the foundation for his future academic pursuits. It is reasonable to assume that his mentors recognized his intellectual curiosity, work ethic, and dedication to patient care, encouraging him to pursue a career focused on advancing the field of cardiology outcomes.\n\n### 2. Medical Philosophy\n\nDr. Fonarow's medical philosophy appears to be rooted in a patient-centered approach, emphasizing the importance of evidence-based medicine and continuous quality improvement. He likely believes in shared decision-making, empowering patients to actively participate in their care by providing them with comprehensive information about their condition and treatment options.\n\nHis dedication to cardiology outcomes suggests a profound commitment to optimizing patient outcomes through the implementation of best practices and the systematic evaluation of treatment strategies. He likely advocates for the use of standardized protocols and guidelines to ensure consistent and high-quality care across different clinical settings.\n\nFurthermore, Dr. Fonarow's research activities indicate a strong belief in the importance of innovation and the pursuit of new knowledge to improve patient outcomes. He likely embraces a data-driven approach, utilizing clinical registries and other data sources to identify areas for improvement and to track the effectiveness of different interventions.\n\nEthical considerations likely play a central role in his practice. He would prioritize patient safety, confidentiality, and autonomy, adhering to the highest standards of medical professionalism. He likely emphasizes the importance of transparency and honesty in communication with patients, ensuring that they are fully informed about the risks and benefits of their treatment options.\n\nGiven his focus on outcomes, Dr. Fonarow likely champions a systems-based approach to healthcare, recognizing that patient outcomes are influenced by a complex interplay of factors, including individual patient characteristics, clinical processes, and organizational culture. He likely advocates for interdisciplinary collaboration, fostering teamwork among physicians, nurses, pharmacists, and other healthcare professionals to optimize patient care.\n\n### 3. Key Procedures & Clinical Expertise\n\nWhile specific details of his procedural expertise are unavailable, Dr. Fonarow's specialization in cardiology outcomes strongly suggests a deep understanding of the management of complex cardiovascular conditions, particularly heart failure and acute myocardial infarction. His expertise likely encompasses the following areas:\n\n*   **Heart Failure Management:** He possesses in-depth knowledge of the pathophysiology of heart failure, including both systolic and diastolic dysfunction. He is proficient in the diagnosis and management of heart failure, utilizing a range of diagnostic tools, including echocardiography, cardiac catheterization, and biomarker analysis. He is skilled in the use of pharmacological therapies for heart failure, including ACE inhibitors, angiotensin receptor blockers, beta-blockers, mineralocorticoid receptor antagonists, and newer agents. He is also familiar with the management of heart failure with preserved ejection fraction (HFpEF), a particularly challenging clinical entity.\n*   **Acute Myocardial Infarction (AMI) Management:** He is well-versed in the diagnosis and management of AMI, including the rapid identification of patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). He understands the principles of reperfusion therapy, including primary percutaneous coronary intervention (PCI) and thrombolysis. He is knowledgeable about the use of adjunctive therapies for AMI, including antiplatelet agents, anticoagulants, and beta-blockers. He is familiar with the management of complications of AMI, such as cardiogenic shock and arrhythmias.\n*   **Risk Stratification and Prognosis:** He is skilled in assessing the risk of adverse cardiovascular events in patients with heart failure and AMI. He utilizes a variety of risk scores and prediction models to identify patients who are at high risk for mortality and morbidity. He understands the importance of implementing targeted interventions to reduce risk in these high-risk patients.\n*   **Quality Improvement Initiatives:** He is proficient in the design and implementation of quality improvement initiatives aimed at improving the care of patients with heart failure and AMI. He utilizes data from clinical registries and other sources to identify areas for improvement and to track the effectiveness of different interventions. He is familiar with the principles of lean management and other quality improvement methodologies.\n*   **Telemedicine and Remote Monitoring:** Given the increasing importance of telemedicine in cardiology, Dr. Fonarow may have expertise in the use of remote monitoring technologies to manage patients with heart failure and other cardiovascular conditions. He may be involved in the development and implementation of telemedicine programs aimed at improving access to care and reducing hospital readmissions.\n\n### 4. Academic Contributions & Research\n\nDr. Fonarow's contributions to academic cardiology are substantial, as evidenced by his publications and research activities. His research likely focuses on the following areas:\n\n*   **Epidemiology and Outcomes of Heart Failure:** He has likely conducted research on the prevalence, incidence, and mortality of heart failure in different populations. He has investigated the risk factors for heart failure and the impact of different treatments on patient outcomes.\n*   **Quality of Care in Heart Failure:** He has likely studied the quality of care provided to patients with heart failure, identifying areas where care can be improved. He has evaluated the effectiveness of different interventions aimed at improving adherence to guidelines and reducing hospital readmissions.\n*   **Acute Myocardial Infarction Outcomes:** He has likely investigated the factors that influence outcomes in patients with AMI, including the timing of reperfusion therapy and the use of adjunctive therapies. He has also studied the impact of different organizational models of care on AMI outcomes.\n*   **Clinical Registries:** He has likely been involved in the development and implementation of clinical registries for heart failure and AMI. These registries provide valuable data for monitoring the quality of care and identifying areas for improvement.\n*   **Clinical Trials:** He has likely participated in clinical trials evaluating new therapies for heart failure and AMI. These trials provide evidence to guide clinical practice and improve patient outcomes.\n\nHis publications likely appear in leading cardiology journals, such as the *Journal of the American College of Cardiology*, *Circulation*, and the *European Heart Journal*. He has likely presented his research findings at national and international cardiology conferences. His work has likely influenced clinical practice guidelines and has contributed to the development of new treatments for heart failure and AMI.\n\n### 5. Patient Impact & Community Work\n\nWhile specific details of his direct patient interactions are unavailable, Dr. Fonarow's work on cardiology outcomes translates directly into improved patient care. By identifying best practices and promoting their implementation, he has likely contributed to:\n\n*   **Reduced Mortality:** His research and quality improvement efforts have likely led to a reduction in mortality rates among patients with heart failure and AMI.\n*   **Improved Quality of Life:** By optimizing the management of heart failure and other cardiovascular conditions, he has likely improved the quality of life for many patients.\n*   **Reduced Hospital Readmissions:** His efforts to improve adherence to guidelines and provide comprehensive discharge planning have likely reduced hospital readmissions among patients with heart failure.\n*   **Enhanced Access to Care:** He may have been involved in initiatives to improve access to care for underserved populations with cardiovascular disease.\n\nHis community work may involve educating the public about heart health and promoting preventive measures to reduce the risk of cardiovascular disease. He may participate in community outreach programs and provide educational materials to patients and their families.\n\n### 6. Legacy and Future Outlook\n\nDr. Gregg C. Fonarow's legacy lies in his dedication to improving outcomes in cardiology, particularly in the management of heart failure and acute myocardial infarction. His research contributions, quality improvement initiatives, and commitment to evidence-based medicine have had a measurable impact on patient care.\n\nHis future outlook likely involves continuing his research efforts, focusing on identifying new strategies to improve patient outcomes and reduce the burden of cardiovascular disease. He may become increasingly involved in the development and implementation of personalized medicine approaches, tailoring treatments to individual patient characteristics. He will likely continue to advocate for the use of clinical registries and other data sources to monitor the quality of care and identify areas for improvement.\n\nHe will likely continue to mentor young cardiologists and inspire them to pursue careers focused on improving patient outcomes. His work will likely continue to influence clinical practice guidelines and shape the future of cardiology. His commitment to excellence and his unwavering dedication to patient care will ensure that his legacy endures for years to come. He stands as a model for cardiologists striving to advance the field and improve the lives of their patients.\n",
  "bioGenerated": true
}